Serum Institute

The DCGI's approval came following recommendation by the Subject Expert Committee (SEC) of the Central Drugs Standard Control…

The vaccine has been developed by the Serum Institute of India (SII), in collaboration with the Oxford University, UK. According…

It will be the first vaccine to be exported to the country by any Indian manufacturer, according to official sources

The EUA application was submitted on 22nd March by Prakash Kumar Singh, Director, Government and Regulatory Affairs, SII

The authorisation is a global first for the age group for the vaccine, which is manufactured and marketed by the Serum Institute…

India's drug regulator had granted restricted Emergency Use Authorisation (EUA) to Covovax for the 12-to-17 year age group subject…

The Drugs Controller General Of India (DCGI) has already approved Covovax for restricted use in emergency situations in adults on…

The Drugs Controller General Of India (DCGI) had approved Covovax for restricted use in emergency situations in adults on 28th…

Sudhir Phatak, Founder, Futurol Consultancy Services, explains how Bharat Biotech, like the sun, with its own R&D, has…

The nanoparticle vaccine, under the brand name Covovax, will be manufactured by Serum Institute of India, and is approved for use…